ClinicalTrials.Veeva

Find clinical trials for Diabetes in Montréal, QC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Macular Edema
Obesity

Diabetes trials near Montréal, QC, CAN:

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease (SUGARNSALT)

inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...

Begins enrollment this month
Diabetic Nephropathies
Diabetes Mellitus Type 1
Drug: Sotagliflozin
Drug: Placebo

Phase 3

Alessandro Doria

Montreal, Quebec, Canada and 18 other locations

Diabetes is one of the biggest public health challenges of the 21st century because of the costs associated with its management, which are e...

Active, not recruiting
Diabetes Mellitus Type 2 in Obese
Diabetes Mellitus Type 2 With Hyperglycemia
Other: Diet
BloomedIn

Saint-Mathieu, Quebec, Canada

A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ technology in adults with type 2 diabetes using b...

Enrolling
Type 2 Diabetes Treated With Insulin
Device: t:slim X2 insulin pump with Control-IQ technology 1.5 and Dexcom G6 CGM
Device: Standard Therapy plus continuous glucose monitoring (CGM)
Tandem Diabetes Care
Tandem Diabetes Care

Montréal, Quebec, Canada and 20 other locations

drug in the treatment of adult participants with a diagnosis of Diabetic Kidney Disease due to either Type 1 diabetes mellitus or T...

Enrolling
Diabetic Kidney Disease
Drug: Placebo
Drug: INV-202

Phase 2

Inversago Pharma

Montreal, Quebec, Canada and 77 other locations

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...

Active, not recruiting
Type 2 Diabetes
Drug: Tirzepatide
Drug: Antihyperglycemic medication

Phase 4

Lilly
Lilly

Montreal, Quebec, Canada and 89 other locations

The purpose of this research study is to evaluate the efficacy and safety of the drugs dapagliflozin and saxagliptin in patients with Type 2 Diabetes...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Placebo
Drug: Saxagliptin

Phase 3

AstraZeneca
AstraZeneca

Montreal, Quebec, Canada and 122 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Montreal, Quebec, Canada and 415 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Placebo (semaglutide)
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Saint-Laurent, Quebec, Canada and 180 other locations

The aim of this study is to test the hypothesis that the effects on albuminuria of combination treatment with the endothelin receptor antagonist zibo...

Invitation-only
Chronic Kidney Diseases
Drug: Zibotentan
Drug: Dapagliflozin and Zibotentan

Phase 2

University Medical Center Groningen (UMCG)

Montreal, Quebec, Canada and 6 other locations

The aim of this study is to test the hypothesis that sotagliflozin (SGLT1/2 inhibitor) and ambrisentan (ERA) combination therapy augments nephroprote...

Not yet enrolling
Type 1 Diabetes Mellitus With Diabetic Nephropathy
Drug: Sotagliflozin
Drug: Ambrisentan and Sotagliflozin

Phase 2

University Medical Center Groningen (UMCG)

Montréal, Quebec, Canada and 6 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems